Solution Structure of the cGMP Binding GAF Domain from Phosphodiesterase 5: INSIGHTS INTO NUCLEOTIDE SPECIFICITY, DIMERIZATION, AND cGMP-DEPENDENT CONFORMATIONAL CHANGE
about
Mechanism for the allosteric regulation of phosphodiesterase 2A deduced from the X-ray structure of a near full-length constructThe Structure of the GAF A Domain from Phosphodiesterase 6C Reveals Determinants of cGMP Binding, a Conserved Binding Surface, and a Large cGMP-dependent Conformational ChangeStructural and Biochemical Characterization of Free Methionine-R-sulfoxide Reductase from Neisseria meningitidisConformation Changes, N-terminal Involvement, and cGMP Signal Relay in the Phosphodiesterase-5 GAF DomainCrystal structure of the GAF-B domain from human phosphodiesterase 5Structures of the PelD Cyclic Diguanylate Effector Involved in Pellicle Formation in Pseudomonas aeruginosa PAO1Structural Mechanism of GAF-Regulated σ54 Activators from Aquifex aeolicusProbing the catalytic sites and activation mechanism of photoreceptor phosphodiesterase using radiolabeled phosphodiesterase inhibitorsCyclic nucleotide binding GAF domains from phosphodiesterases: structural and mechanistic insightscGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.Structural rearrangement accompanying ligand binding in the GAF domain of CodY from Bacillus subtilis.Cyclic nucleotide binding and structural changes in the isolated GAF domain of Anabaena adenylyl cyclase, CyaB2.Characterization of conformational changes and protein-protein interactions of rod photoreceptor phosphodiesterase (PDE6).Targeting cancer with phosphodiesterase inhibitors.Distinct allostery induced in the cyclic GMP-binding, cyclic GMP-specific phosphodiesterase (PDE5) by cyclic GMP, sildenafil, and metal ions
P2860
Q24336151-6FA52B34-30E0-4861-AA15-98D11D92B276Q27651104-225D16FE-D565-4C92-954E-7E063F2A35DBQ27661762-7FB22887-44BF-4619-BADC-F8FC0A72D88DQ27664639-251D33D3-7999-46E7-933A-AA9C2AA51350Q27667079-11EF85DB-945E-412B-A62C-171DFEB63779Q27670796-BD1588EA-F2FF-412C-A999-E9C5E35B30DAQ27674966-A0E266ED-5975-4FAE-BD74-80C9272E979DQ33553642-D84D47C1-81EF-49F9-BE63-975E76624D86Q33571750-F156DEBB-114A-4000-A2F1-6989DDEA3709Q34244951-E0B7A65A-3D3E-487D-84E9-83FDB1B2D5E6Q34765802-E411BBCA-978D-40A7-B93A-211ED37BAE3DQ35084439-3A99405F-7D15-4BC2-93D5-D44FCFBB792CQ35543822-EB65BAF8-49E9-47DD-8E66-504E4B7E841EQ36016840-467FC224-E5C5-4B1A-9ABD-A2E2C1406BB1Q37650389-2440E80A-8EA7-44C1-9602-0DC26DA0C647Q42650059-B8F34084-5E47-4557-AED5-0EE83E8FCA27
P2860
Solution Structure of the cGMP Binding GAF Domain from Phosphodiesterase 5: INSIGHTS INTO NUCLEOTIDE SPECIFICITY, DIMERIZATION, AND cGMP-DEPENDENT CONFORMATIONAL CHANGE
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Solution Structure of the cGMP ...... EPENDENT CONFORMATIONAL CHANGE
@ast
Solution Structure of the cGMP ...... EPENDENT CONFORMATIONAL CHANGE
@en
Solution Structure of the cGMP ...... EPENDENT CONFORMATIONAL CHANGE
@nl
type
label
Solution Structure of the cGMP ...... EPENDENT CONFORMATIONAL CHANGE
@ast
Solution Structure of the cGMP ...... EPENDENT CONFORMATIONAL CHANGE
@en
Solution Structure of the cGMP ...... EPENDENT CONFORMATIONAL CHANGE
@nl
prefLabel
Solution Structure of the cGMP ...... EPENDENT CONFORMATIONAL CHANGE
@ast
Solution Structure of the cGMP ...... EPENDENT CONFORMATIONAL CHANGE
@en
Solution Structure of the cGMP ...... EPENDENT CONFORMATIONAL CHANGE
@nl
P2093
P2860
P356
P1476
Solution Structure of the cGMP ...... EPENDENT CONFORMATIONAL CHANGE
@en
P2093
Catherine M Eakin
Clemens C Heikaus
Joseph A Beavo
Joseph R Stout
Monica R Sekharan
Peter S Brzovic
Ponni Rajagopal
Rachel E Klevit
P2860
P304
P356
10.1074/JBC.M801577200
P407
P577
2008-08-15T00:00:00Z